⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6025560 | 0.97 | — | — | |
| SCHEMBL30000995 | 0.93 | — | — | |
| SCHEMBL1493545 | 0.79 | — | — | |
| SCHEMBL28791934 | 0.79 | — | — | |
| SCHEMBL221057 | 0.75 | — | — | |
| SCHEMBL28693375 | 0.75 | HPGD (0.39) | — | |
| SCHEMBL31672170 | 0.73 | — | — | |
| SCHEMBL28865074 | 0.72 | CA1 (0.33) | — | |
| SCHEMBL28561664 | 0.72 | FAAH (0.48) | — | |
| SCHEMBL28558022 | 0.72 | FAAH (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112661684-A | Method for synthesizing long-chain alkyl coenzyme M | 农业部沼气科学研究所 | 2021-04-16 | — | — | CN | claimed |
| CN-108905883-A | A kind of preparation method of Si-C-Si type anionic organic silicon surfactant | 九江学院 | 2018-11-30 | — | — | CN | claimed |
| CN-104334561-B | compound JK12A and preparation thereof | 连云港金康和信药业有限公司 | 2016-06-22 | — | — | CN | claimed |
| CN-104334561-A | Compound JK12A and preparation thereof | LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO LTD | 2015-02-04 | — | — | CN | claimed |
| CN-102846632-A | Inhalant containing sodium 2-mercaptoethane sulfonate and ciclesonide and preparation method thereof | TIANJIN JINYAO GROUP CO LTD | 2013-01-02 | — | — | CN | claimed |
| CN-102846631-A | Inhalant containing sodium 2-mercaptoethane sulfonate and budesonide and preparation method thereof | TIANJIN JINYAO GROUP CO LTD | 2013-01-02 | — | — | CN | claimed |
| CN-102846626-A | Inhalation preparation containing sodium mercaptoethane sulfonate and Fluticasone propionate | TIANJIN JINYAO GROUP CO LTD | 2013-01-02 | — | — | CN | claimed |
| CN-102847151-A | Inhalant preparation containing sodium 2-mercaptoethanesulfonate and glucocorticoid | TIANJIN JINYAO GROUP CO LTD | 2013-01-02 | — | — | CN | claimed |
| CN-102846630-A | Inhalant containing sodium 2-mercaptoethane sulfonate and mometasone furoate and preparation method thereof | TIANJIN JINYAO GROUP CO LTD | 2013-01-02 | — | — | CN | claimed |
| CN-101775065-A | Positioning and marking method of protein | HANGZHOU YAODU BIOTECHNOLOGY C | 2010-07-14 | — | — | CN | claimed |
| CN-101415394-A | Personal care article | RECKITT BENCKISER UK LTD (GB) | 2009-04-22 | — | — | CN | claimed |
| CN-112661684-A | Method for synthesizing long-chain alkyl coenzyme M | 农业部沼气科学研究所 | 2021-04-16 | — | — | CN | disclosed |
| CN-112661684-A | Method for synthesizing long-chain alkyl coenzyme M | 农业部沼气科学研究所 | 2021-04-16 | — | — | CN | disclosed |
| CN-108905883-A | A kind of preparation method of Si-C-Si type anionic organic silicon surfactant | 九江学院 | 2018-11-30 | — | — | CN | disclosed |
| CN-106010059-B | The fluorinated film of hydrophilic modifying | 帕尔公司 | 2018-07-06 | — | — | CN | disclosed |
| US-5902610-A | ADMINISTERING WITH OR WITHOUT CISPLATIN IN THE SAME FORMULATION, TO REDUCE TOXIC SIDE EFFECTS OF CISPLATIN IN CANCER THERAPY AND POTENTIATE ITS ANTITUMOR ACTIVITY | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1999-05-11 | — | — | US | disclosed |
| US-5866617-A | AQUEOUS SOLUTION FOR ADMINISTRATION TO PATIENTS ALSO RECEIVING CISPLATIN; REDUCED SIDE EFFECTS, INCREASED ANTITUMOR ACTIVITY | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| US-5866169-A | LYOPHILIZED FORMULATION WITH CISPLATIN; REDUCED SIDE EFFECTS, INCREASED ANTITUMOR ACTIVITY | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| US-5866615-A | LYOPHILIZED FORMULATION WITH ANTICANCER AGENTS; REDUCED SIDE EFFECTS, INCREASED ACTIVITY | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| US-5789000-A | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1998-08-04 | — | — | US | disclosed |